集团为一家投资控股公司，公司专注以重组DNA技术为基础开发生物药品。集团的主要业务为生产及销售治疗体表创伤和眼部损伤的生物药品及研发治疗十二指肠溃疡及神经系统损伤及疾病的生物药品以及其它眼科药物项目。现有两类已投入商业生产的生物药品，分别为贝复济系列，包括液体剂型，冻干粉剂型及凝胶剂型和贝复舒系列，包括滴眼液及凝胶剂型，两者分别用以治疗急性及慢性体表创伤和角膜损伤。
View Top Employees from 珠海亿胜生物制药有限公司| Website | http://essexbio.com |
| Revenue | $150 million |
| Employees | 45 (16 on RocketReach) |
| Founded | 2000 |
| Address | Room 2818 China Merchants Tower Shun Tak Centre 168-200 Connaught Road Central, Hong Kong SAR, CN |
| Phone | +86 756 391 1185 |
| Industry | Drug Stores & Pharmacies, Biotechnology, Retail, Science and Engineering |
| Web Rank | 11 Million |
| Keywords | 珠海亿胜生物, Recombinant Bovine Basic Fibroblast Growth Factor Gel Warts, 億勝生物科技, Bfgf |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular 珠海亿胜生物制药有限公司 employee's phone or email?
珠海亿胜生物制药有限公司 Questions
The 珠海亿胜生物制药有限公司 annual revenue was $150 million in 2023.
Quinn Xue is the Chief Scientific Officer of 珠海亿胜生物制药有限公司.
16 people are employed at 珠海亿胜生物制药有限公司.
The NAICS codes for 珠海亿胜生物制药有限公司 are [32, 3254, 325, 32541].
The SIC codes for 珠海亿胜生物制药有限公司 are [283, 28].
Top 珠海亿胜生物制药有限公司 Employees
Related Companies
